IP Library Granted Patent US 12,435,394
Granted Patent B2
US 12,435,394 · App. 17/610,575 · Granted Oct 7, 2025

Intermetallic compounds of cobalt as targets for the production of theranostic radionuclides

Inventors: Paul A. Ellison (Madison, WI); Robert Jerome Nickles (Madison, WI); Todd E. Barnhart (Madison, WI); Jonathan W. Engle (Middleton, WI); Christopher J. Kutyreff (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C22C19/07G21G1/10G21G4/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,435,394
App. No.
17/610,575
Granted
Oct 7, 2025
Kind
B2
Abstract

Cobalt intermetallic compounds that include cobalt and a second element are provided. The isotopes of the second element in the compounds are present in their natural isotopic abundance or in an enriched isotopic abundance. Methods of making the compounds and methods of using the compounds as targets in the production of radionuclides are further provided.

Claims (8)

1. A method of generating a radionuclide comprising bombarding a target material comprising an isotopically enriched cobalt intermetallic compound of comprising cobalt and selenium with bombarding particles in a particle accelerator, wherein the selenium is isotopically enriched in the target material and the target material contains from 50 mol. % to 60 mol. % of the selenium wherein the bombarding particles have energies that are sufficiently high to induce a nuclear reaction that produces the radionuclide from the cobalt intermetallic compound.

2. The method of claim 1 , wherein the particle accelerator is a proton accelerator.

3. The method of claim 2 , wherein the proton accelerator is a cyclotron.

4. The method of claim 1 , wherein the radionuclide is a radionuclide of bromine.

5. The method of claim 1 , wherein the radionuclide is a radionuclide of arsenic.

6. A target material comprising an isotopically enriched cobalt intermetallic compound comprising cobalt and selenium, wherein the selenium is isotopically enriched in the target material, and further wherein the target material contains from 50 mol. % to 60 mol. % of the selenium.

7. The target material of claim 6 , wherein the target material is in a form of a disc or a pellet.

8. The target material of claim 6 , wherein the selenium in the isotopically enriched cobalt intermetallic compound is a selenium isotope selected from the group consisting of 76 Se, 77 Se, 78 Se, and 80 Se.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 18, 2022
From: UNIVERSITY OF WISCONSIN-MADISON
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 060201/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2021
From: ELLISON, PAUL; BARNHART, TODD; KUTYREFF, CHRISTOPHER; ENGLE, JONATHAN; NICKLES, ROBERT
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 058123/0608 →
Continuity (2)
Provisional Application 62859814 · Jun 11, 2019
Related Publication 20220220586A1 · Jul 14, 2022
References Cited (18)
US 8098789B2 · Nye · 2012 [cited by examiner]
US 20070064858A1 · Nye · 2007 [cited by examiner]
US 20130170593A1 · Jansen et al. · 2013 [cited by applicant]
US 20150003576A1 · Uhland et al. · 2015 [cited by applicant]
US 20170316855A1 · Deligianni · 2017 [cited by examiner]
US 20180211737A1 · Pipes · 2018 [cited by applicant]
US 20190019591A1 · Uhland et al. · 2019 [cited by applicant]
EP 3557955A1 · 2019 [cited by examiner]
WO WO2018007643 · 2018 [cited by applicant]
NPL-1: Experimental studies and nuclear model calculations on proton-induced reactions on natSe, 76Se and 77Se with particular reference to the production of the medically interesting radionuclides 76Br and 77Br, Applie… [cited by examiner]
Hassan et al., “Investigation of selenium compounds as targets for [cited by applicant]
Yoshinaga et al., “Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging—From basic aspects to clinical applications,” [cited by applicant]
P.W. Schmor, “Review of Cyclotrons Used in the Production of Radio-Isotopes for Biomedical Applications,” [cited by applicant]
International Search Report and Written Opinion for PCT/US2020/033397, mailed Aug. 27, 2020. [cited by applicant]
Kutyreff et al., “Ga—Co Compounds for Production of Germanium Radioisotopes,” Abstract from 17th Workshop on Targetry and Target Chemistry, Coimbra, Portugal, Aug. 2018. [cited by applicant]
Das et al, “Production of [cited by applicant]
Ellison et al., “Improved production of [cited by applicant]
Jansen et al., “The Reactions [cited by applicant]